Skip to main content
. 2017 Apr 22;4(4):208–222. doi: 10.1016/j.ajur.2017.04.001

Table 1.

IADT guidelines.

Guideline Recommendation
AUA 2007 update
  • IADT not being discussed

ASCO 2007 update
  • More studies with longer follow-up and with larger patient cohorts are needed to determine the impact of IADT

EAU 2015
  • IADT could maintain QoL in off-treatment periods and is significantly associated with lower treatment costs

  • IADT may provide an option for patients in metastatic stage

NCCN 2015
  • IADT could reduce side-effects and may improve QoL, however, the benefits are unclear

IADT, intermittent androgen deprivation therapy; QoL, quality of life.